ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 164 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $529,253 | -28.8% | 115,055 | 0.0% | 0.20% | -29.6% |
| Q2 2023 | $743,255 | -14.3% | 115,055 | 0.0% | 0.29% | -23.9% |
| Q1 2023 | $867,515 | -25.6% | 115,055 | 0.0% | 0.38% | -31.7% |
| Q4 2022 | $1,165,507 | -80.9% | 115,055 | -81.4% | 0.55% | -77.8% |
| Q3 2022 | $6,104,000 | -9.1% | 617,213 | -2.1% | 2.49% | -6.3% |
| Q2 2022 | $6,713,000 | +49.2% | 630,326 | +36.6% | 2.66% | +71.5% |
| Q1 2022 | $4,498,000 | -31.8% | 461,289 | 0.0% | 1.55% | -20.7% |
| Q4 2021 | $6,596,000 | -28.6% | 461,289 | 0.0% | 1.96% | -29.3% |
| Q3 2021 | $9,244,000 | – | 461,289 | – | 2.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |